Profusa, Inc.

Profusa, Inc. (PFSA) is a digital health and medical technology company specializing in continuous biosensor technology, with a core platform centered on tissue-integrated implantable sensors designed for real-time monitoring of body chemistry. Operating in the health technology and wearable medical device sector, Profusa became a publicly traded company through a SPAC transaction and has since maintained its reporting obligations as an SEC filer. The company submitted a Form 10-Q on June 13, 2025, bearing accession number 0001213900-25-054386, covering quarterly financial and operational disclosures. For full sponsor details, deal history, and analytics on PFSA and the broader de-SPAC universe, sign up for complete data on SpacDesk.